Nidan Laboratories & Healthcare Limited Stock Price Today (NSE: NIDAN)
Nidan Laboratories & Healthcare Limited
Fundamental Score
Nidan Laboratories & Healthcare Limited Share Price — Live NSE/BSE Price, Fundamentals & Analysis
Nidan Laboratories & Healthcare Limited share price today is ₹13.45, up +0.00% on NSE/BSE as of 7 August 2026. Nidan Laboratories & Healthcare Limited (NIDAN) is a Small-cap company in the Healthcare Service Provider sector with a market capitalisation of ₹19.39 (Cr). The 52-week high for NIDAN share price is ₹23.60 and the 52-week low is ₹12.45. At a P/E ratio of 11.02x, NIDAN is currently trading below its industry average P/E of 42.23x. The company has a Return on Equity (ROE) of 2.55% and a debt-to-equity ratio of 0.16.
Nidan Laboratories & Healthcare Limited Share Price Chart — NSE/BSE Historical Performance
Nidan Laboratories & Healthcare Limited share price chart: -4.95% return over the past month. 52-week high ₹23.60, 52-week low ₹12.45.
Nidan Laboratories & Healthcare Limited — Last 10 Trading Days
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| ₹13.45 | ₹13.45 | ₹13.45 | ₹13.45 | 2.00K (Cr) | |
| ₹13.25 | ₹13.25 | ₹13.25 | ₹13.25 | 1.00K (Cr) | |
| ₹13.25 | ₹13.25 | ₹13.10 | ₹13.10 | 4.00K (Cr) | |
| ₹13.85 | ₹13.85 | ₹12.45 | ₹13.00 | 8.00K (Cr) | |
| ₹13.45 | ₹13.45 | ₹13.45 | ₹13.45 | 2.00K (Cr) | |
| ₹13.40 | ₹13.40 | ₹13.15 | ₹13.15 | 4.00K (Cr) | |
| ₹12.70 | ₹12.70 | ₹12.50 | ₹12.50 | 5.00K (Cr) | |
| ₹13.45 | ₹13.45 | ₹12.80 | ₹12.90 | 5.00K (Cr) | |
| ₹12.70 | ₹13.00 | ₹12.70 | ₹12.95 | 7.00K (Cr) | |
| ₹12.95 | ₹13.95 | ₹12.95 | ₹13.95 | 4.00K (Cr) |
Nidan Laboratories & Healthcare Limited — Last 12 Months Price History
| Month | Open | High | Low | Close | Change |
|---|---|---|---|---|---|
| ₹13.85 | ₹13.85 | ₹12.45 | ₹13.45 | -2.89% | |
| ₹12.55 | ₹14.55 | ₹12.50 | ₹13.45 | +7.17% | |
| ₹14.00 | ₹14.20 | ₹13.20 | ₹14.20 | +1.43% | |
| ₹13.95 | ₹15.00 | ₹13.15 | ₹14.55 | +4.30% | |
| ₹13.75 | ₹15.60 | ₹13.75 | ₹14.95 | +8.73% | |
| ₹15.80 | ₹15.80 | ₹13.40 | ₹13.90 | -12.03% | |
| ₹15.00 | ₹17.50 | ₹15.00 | ₹17.50 | +16.67% | |
| ₹18.80 | ₹19.00 | ₹15.15 | ₹15.25 | -18.88% | |
| ₹23.60 | ₹23.60 | ₹18.55 | ₹18.65 | -20.97% | |
| ₹19.85 | ₹20.75 | ₹19.10 | ₹19.25 | -3.02% | |
| ₹18.25 | ₹19.50 | ₹17.85 | ₹19.50 | +6.85% | |
| ₹18.10 | ₹19.55 | ₹17.85 | ₹18.25 | +0.83% |
Returns & Performance
Return on Equity (ROE)
Profit generated per ₹1 of shareholder equity
Return on Capital (ROCE)
Returns generated on total capital deployed
Oper. Profit Margin (5Y Avg)
Average operating profit margin over 5 years
Dividend Yield
Annual dividend as % of current share price
Nidan Laboratories & Healthcare Limited Valuation Check
Price to Earnings (P/E)
Share price ÷ earnings per share. Lower = cheaper
Industry Avg P/E
Average P/E of all peers in this sector
Market Capitalisation
Total market value of all outstanding shares
Growth Engine
Profit Growth (Quarterly YoY)
Net profit growth vs same quarter last year
Revenue Growth (Quarterly YoY)
Revenue growth vs same quarter last year
Revenue Growth (5-Year CAGR)
Compounded annual revenue growth over 5 years
EPS Growth (5-Year CAGR)
Earnings per share growth over 5 years
Net Profit Growth (5-Year CAGR)
Compounded annual net profit growth over 5 years
Balance Sheet Health
Debt to Equity Ratio
Total debt ÷ equity. Below 0.5 = financially healthy
Interest Coverage Ratio
EBIT ÷ interest expense. Above 2.5 = can pay interest comfortably
Free Cash Flow (5-Year Total)
Cash left after capex over 5 years. Positive = self-funded growth
Labels (e.g., "Excellent", "Good") are peer-based vs industry/sector averages — data-only, not advice
Nidan Laboratories & Healthcare Limited Fundamental Analysis & Valuation Benchmarking
Educational evaluation of NIDAN across key market metrics for learning purposes.
Positive Indicators
5 factors identified
Strong Operating Margins (25.39%)
Observation: Healthy 5-year operating margins indicate pricing power and cost control.
Analysis: OPM >15% suggests operational efficiency and competitive advantages.
Attractive Valuation (P/E: 11.02 vs Industry: 42.23)
Observation: Trading at discount to industry peers.
Analysis: P/E below industry average may present value opportunity.
Conservative Debt Levels (D/E: 0.16)
Observation: Low leverage provides financial flexibility and reduced risk.
Analysis: Conservative debt structure offers resilience during economic downturns.
Balanced Promoter Holding (57.04%)
Observation: Optimal balance between promoter control and public float.
Analysis: Promoter holding in 50-75% range provides management alignment.
Zero Share Pledging Risk
Observation: No promoter shares pledged as collateral.
Analysis: Absence of share pledging eliminates potential forced-selling pressure.
Risk Factors
9 factors identified
Below-Average Return on Equity (2.55%)
Observation: Returns on equity are below industry benchmarks.
Analysis: ROE <10% may indicate inefficient capital utilization. Consider monitoring for operational improvements and management effectiveness.
Suboptimal ROCE (5.99%)
Observation: Returns on capital employed are below expectations.
Analysis: ROCE <10% suggests potential inefficiencies in capital allocation.
Profit Decline Concern (-86.36%)
Observation: Significant year-over-year profit contraction observed.
Analysis: Declining profitability requires investigation into underlying causes.
Revenue Contraction (-11.22%)
Observation: Sales decline may indicate market challenges or competitive pressures.
Analysis: Negative revenue growth requires analysis of market conditions.
Limited Growth History (4.62% CAGR)
Observation: Below-average 5-year sales growth trajectory.
Analysis: Low sales CAGR may indicate mature markets or limited growth opportunities.
Weak Earnings Growth (-11.43% CAGR)
Observation: Below-average 5-year EPS growth performance.
Analysis: Low EPS growth may not keep pace with inflation.
Stagnant Profit Growth (-5.21% CAGR)
Observation: Limited 5-year profit growth trajectory.
Analysis: Low profit growth may indicate scalability challenges or market maturity.
Weak Interest Coverage (2.45x)
Observation: Limited ability to service debt obligations from earnings.
Analysis: Low interest coverage raises concerns about financial stability.
No Dividend Distribution
Observation: Company does not currently pay dividends to shareholders.
Analysis: Zero dividend yield may indicate growth reinvestment focus or cash flow constraints.
Nidan Laboratories & Healthcare Limited vs Healthcare Service Provider Peers
Peer Comparison - Healthcare Service Provider
Compare Nidan Laboratories & Healthcare Limited with 10 other companies in the same sector
| Company Info | Fundamental | Valuation | Profitability | Financial Health | Growth | Dividend | ||||
|---|---|---|---|---|---|---|---|---|---|---|
Company Company name | Score Bull Run comprehensive fundamental score based on 20+ metrics | Price Current trading price of the stock | Market Cap Total value of all shares in the market | P/E Price per share divided by earnings per share | ROE Net income divided by shareholder equity | ROCE Earnings before interest and tax divided by capital employed | Debt/Eq Total debt divided by total equity | Profit 5Y Average annual profit growth over 5 years | Sales 5Y Average annual sales growth over 5 years | Dividend Annual dividend per share divided by price per share |
31.5/100 | ₹13.45₹13 | ₹19.39₹19.39 | 11.02Average 11.0 Average | 2.55%Poor 2.55% Poor | 5.99%Poor 5.99% Poor | 0.16Excellent 0.2 Excellent | -5.21%Poor -5.21% Poor | 4.62%Average 4.62% Average | 0.00% | |
Dr Lal PathLabs LtdDr Lal PathLabs... LALPATHLAB • 539524 | 57.7/100 | ₹1905.20₹1905 | ₹28908.91₹28908.91 | 55.39Average 55.4 Average | 22.30%Excellent 22.30% Excellent | 28.00%Excellent 28.00% Excellent | 0.08Excellent 0.1 Excellent | 12.33%Good 12.33% Good | 11.81%Good 11.81% Good | 0.81% |
Vijaya Diagnostic Centre LtdVijaya Diagnost... VIJAYA • 543350 | 67.8/100 | ₹1344.40₹1344 | ₹14307.85₹14307.85 | 82.71Average 82.7 Average | 19.74%Good 19.74% Good | 21.29%Excellent 21.29% Excellent | 0.44Excellent 0.4 Excellent | 15.47%Excellent 15.47% Excellent | 16.66%Excellent 16.66% Excellent | 0.14% |
Metropolis Healthcare LtdMetropolis Heal... METROPOLIS • 542650 | 57.9/100 | ₹582.45₹582 | ₹11858.49₹11858.49 | 60.38Average 60.4 Average | 13.81%Average 13.81% Average | 17.77%Good 17.77% Good | 0.15Excellent 0.1 Excellent | 1.46%Average 1.46% Average | 10.52%Good 10.52% Good | 0.35% |
Thyrocare Technologies LtdThyrocare Techn... THYROCARE • 539871 | 46.7/100 | ₹579.00₹579 | ₹8420.27₹8420.27 | 52.36Average 52.4 Average | 28.40%Excellent 28.40% Excellent | 35.38%Excellent 35.38% Excellent | 0.09Excellent 0.1 Excellent | 8.37%Good 8.37% Good | 10.88%Good 10.88% Good | 1.76% |
Krsnaa Diagnostics LtdKrsnaa Diagnost... KRSNAA • 543328 | 31.9/100 | ₹527.45₹527 | ₹1777.47₹1777.47 | 17.31Average 17.3 Average | 10.89%Average 10.89% Average | 12.70%Average 12.70% Average | 0.54Good 0.5 Good | -11.13%Poor -11.13% Poor | 11.75%Good 11.75% Good | 0.50% |
Suraksha Diagnostic LtdSuraksha Diagno... SURAKSHA • 544293 | 56.2/100 | ₹252.15₹252 | ₹1359.30₹1359.30 | 42.23Average 42.2 Average | 14.12%Average 14.12% Average | 16.97%Good 16.97% Good | 0.53Good 0.5 Good | 31.68%Excellent 31.68% Excellent | 17.26%Excellent 17.26% Excellent | 0.00% |
One Global Service Provider IncOne Global Serv... ONEGLOBAL • 514330 | 82.2/100 | ₹564.95₹565 | ₹1178.25₹1178.25 | 16.95Average 16.9 Average | 65.27%Excellent 65.27% Excellent | 87.02%Excellent 87.02% Excellent | 0.00Excellent 0.0 Excellent | 97.21%Excellent 97.21% Excellent | 167.02%Excellent 167.02% Excellent | 0.00% |
3B Blackbio Diagnostics Ltd3B Blackbio Dia... 3BBLACKBIO • 532067 | 60.3/100 | ₹1248.10₹1248 | ₹1079.13₹1079.13 | 18.42Average 18.4 Average | 19.77%Good 19.77% Good | 25.48%Excellent 25.48% Excellent | 0.01Excellent 0.0 Excellent | -12.44%Poor -12.44% Poor | -8.95%Poor -8.95% Poor | 0.31% |
Sastasundar Ventures LtdSastasundar Ven... SASTASUNDR • 533259 | 39/100 | ₹301.45₹301 | ₹1035.54₹1035.54 | 539.34Average 539.3 Average | 0.29%Poor 0.29% Poor | -0.05%Poor -0.05% Poor | 0.04Excellent 0.0 Excellent | 16.91%Excellent 16.91% Excellent | 19.09%Excellent 19.09% Excellent | 0.00% |
49.4/100 | ₹239.10₹239 | ₹600.78₹600.78 | 20.55Average 20.6 Average | 19.92%Good 19.92% Good | 23.27%Excellent 23.27% Excellent | 0.31Excellent 0.3 Excellent | — — | — — | 0.00% | |
Top Healthcare Service Provider Stocks
View all →By Bull Run Score
By Return on Equity
By Market Cap
- Dr Lal PathLabs Ltd share price28908.91 Cr
- Vijaya Diagnostic Centre Ltd share price14307.85 Cr
- Metropolis Healthcare Ltd share price11858.49 Cr
- Thyrocare Technologies Ltd share price8420.27 Cr
- Krsnaa Diagnostics Ltd share price1777.47 Cr
Nidan Laboratories & Healthcare Limited Quarterly Performance
Latest quarterly metrics for NIDAN — revenue growth and profit growth vs same quarter last year
Revenue Growth (YoY)
-11.22%
Latest quarter vs same quarter previous year
Net Profit Growth (YoY)
-86.36%
Latest quarter net profit vs same quarter previous year
5-Year Revenue CAGR
4.62%
Compounded annual revenue growth over 5 years
5-Year Profit CAGR
-5.21%
Compounded annual net profit growth over 5 years
Nidan Laboratories & Healthcare Limited Technical Indicators
SMA 50, SMA 200, RSI and volume signals for NIDAN — calculated from daily price history
Momentum is balanced — neither overbought nor oversold.
Technical indicators are for educational purposes only. Not investment advice.
Nidan Laboratories & Healthcare Limited Financial Statements
Annual income statement, balance sheet and cash flow for Nidan Laboratories & Healthcare Limited (NIDAN) — sourced from NSE/BSE filings.
Loading Financial Statements...
Fetching financial data for Nidan Laboratories & Healthcare Limited
About NIDAN (Nidan Laboratories & Healthcare Limited)
Nidan Laboratories & Healthcare Limited (NIDAN) is listed on the National Stock Exchange (NSE) and Bombay Stock Exchange (BSE) of India. The company operates in the Healthcare Serv...ice Provider sector with a current market capitalisation of ₹19.39 (Cr). Nidan Laboratories & Healthcare Limited has delivered a Return on Equity (ROE) of 2.55% and a ROCE of 5.99%. The debt-to-equity ratio stands at 0.16, reflecting the company's capital structure. Investors tracking NIDAN share price can monitor key metrics including P/E ratio, promoter holding of 57.04%, and quarterly earnings growth.
Company Details
NIDAN Share Price: Frequently Asked Questions
What is the current share price of Nidan Laboratories & Healthcare Limited?
Nidan Laboratories & Healthcare Limited (NIDAN) trades at ₹13.45 on NSE. Market cap ₹19.39 (Cr). Educational data only.
What is the P/E ratio of Nidan Laboratories & Healthcare Limited?
Nidan Laboratories & Healthcare Limited has a P/E of 11.02x vs industry average 42.23x.
What is the Bull Run score for Nidan Laboratories & Healthcare Limited?
Nidan Laboratories & Healthcare Limited has a Bull Run score of 31.5/100 based on 25+ financial parameters.
Does Nidan Laboratories & Healthcare Limited pay dividends?
Nidan Laboratories & Healthcare Limited has a dividend yield of 0.00%. Past dividends don't guarantee future payments.
What is the ROE of Nidan Laboratories & Healthcare Limited?
Nidan Laboratories & Healthcare Limited has ROE of 2.55%. Higher ROE indicates better use of shareholder equity.
What is the debt-to-equity ratio of Nidan Laboratories & Healthcare Limited?
Nidan Laboratories & Healthcare Limited has debt-to-equity of 0.16.
Is Nidan Laboratories & Healthcare Limited a good investment?
Bull Run gives Nidan Laboratories & Healthcare Limited a score of 31.5/100. This is not investment advice — consult a SEBI-registered advisor.